Julien Vaucher

MD, Head Internal Medicine #HFR-Hôpital_fribourgeois; Prof @UniFR; MD @CHUVLausanne & PI @ father of 3; 🚲-addict (when enough time)

[Julien Vaucher @JulienVaucher]

A small piece on "COVID-19 pandemic and cardiovascular disease" - will there be a double sentence ?https://t.co/iSjhJnFErl

[Joe Biden @JoeBiden]

My fellow Democrats, I have decided not to accept the nomination and to focus all my energies on my duties as President for the remainder of my term. My very first decision as the party nominee in 2020 was to pick Kamala Harris as my Vice President. And it’s been the best decision I’ve made. Today I want to offer my full support and endorsement for Kamala to be the nominee of our party this year. Democrats — it’s time to come together and beat Trump. Let’s do this.

[Julien Vaucher @JulienVaucher]

A huge endeavor by #guillaumejordan and colleagues to spatially localize cardiovascular risk factors and disease longitudinally exploiting #CoLaus|PsyCoLaus data https://t.co/4dHMnAomWe thanks for the great collaboration!

[Julien Vaucher @JulienVaucher]

@zkutalik Further studies are needed to replicate our findings, and to investigate more precisely the risk of ASCVD in relation to the quantity, type, route of administration, or the age at exposure to cannabis.

[Julien Vaucher @JulienVaucher]

Using a genetic approach (Mendelian randomization) cannabis use is not causally associated with risk of coronary artery disease or ischeamic stroke ! well done @roxanedelaharpe @zkutalik https://t.co/0JosWB4kea

[Julien Vaucher @JulienVaucher]

😴 Quality of sleep associates with cardiovascular disease ! Good sleep could subtantially improve your cardiovascular health ! 😴
Great work using #PPSIII and #CoLaus|PsyCoLaus studies!! 🙌💤 (going to sleep) https://t.co/fWo0fgneOw

[Julien Vaucher @JulienVaucher]

@iguessous @UNIGEnews Félicitations!

[idris guessous @iguessous]

Latest work by Nehme et al ⁦@Hopitaux_unige⁩ ⁦@UNIGEnews⁩ #SMPR published in ⁦⁦@SciReports⁩ Healthcare workers and consequences of the pandemic burden, a longitudinal study https://t.co/ptirdf3cMJ

[Yoan Rithner @YoanRithner]

Le quartier du #Flon à #Lausanne se réveille groggy, après l’attaque de vitrines perpétrée cette nuit par une centaine de jeunes. Les rassemblements se sont organisés sur les réseaux sociaux, en représailles au décès de #Nahel en France. @RTSinfo

[Julien Vaucher @JulienVaucher]

👋 want to know how EU (SCORE2) and US (PCE) compare?!? ➡️ read: Comparison of the European and U.S. guidelines for lipid-lowering therapy in primary prevention of cardiovascular disease https://t.co/nhlyDVHNQ9 BRAVO to @BenoitDelabays & @Roxanedelaharpe!!! 👏👏👏

[Julien Vaucher @JulienVaucher]

@timfrayling Woaouuuu! Welcome in 🇨🇭!!!

[Julien Vaucher @JulienVaucher]

🤚Join us in Fribourg Switzerland 🇨🇭for a (MD-)PhD thesis in genetic epidemiology! 🙌 You'll be part of a large consortium, learn a lot of stuffs and enjoy the place!

[Communications Biology @CommsBio]

MRI data from over 1000 participants between the ages of 46 and 87 reveals that cardiovascular risk factors are associated with myelin loss and neuroinflammation in the brain: https://t.co/deermw64cI

[Le Temps @LeTemps]

Les Prix scientifiques 2023 de la fondation récompensent des recherches sur la résistance aux antibiotiques, sur la lutte contre certains symptômes de la schizophrénie, et sur les maladies cardiovasculaires développées en l’absence de facteurs de risque https://t.co/dmPaEvb9SY

[Julien Vaucher @JulienVaucher]

@WaelPascha Certainement, mais vu la lumière dehors c’est pas un peu tôt? 😊 (désolé déformation professionnelle)…

[Jason H. Moore, PhD @moorejh]

#balloonwars

[Département de médecine / CHUV @DptMedecineCHUV]

❤️‍🩹Affiner la #prevention #cardiovasculaire grâce au score polygénique 🧬
Une étude réalisée à partir des données de #cohorte CoLaus I PsyCoLaus par Roxane de La Harpe, Service de médecine interne et Christian W. Thorball, Unité de médecine de précision
➡️https://t.co/j6OECLQDDr

[Julien Vaucher @JulienVaucher]

Next step would be to design proper pragmatic RCT using PRS to seek its added value in clinics and cost-effectiveness…

[Julien Vaucher @JulienVaucher]

Great work by Roxane & Christian on an important issue in clinical practice! @DptMedecineCHUV @CHUVLausanne Combining European and U.S. risk prediction models with polygenic risk scores to refine cardiovascular prevention: the CoLaus|PsyCoLaus Study https://t.co/oKPvp20sg8

[Julien Vaucher @JulienVaucher]

Indeed about 10% of people at intermediate risk (SCORE2 or PCE) were correctly reclassified. PRS do not fill the gap of uncertainty in CV prevention but represents a step forward 👍🏻